Aspirin Use and Respiratory Morbidity in COPD: A Propensity Score-Matched Analysis in Subpopulations and Intermediate Outcome Measures in COPD Study

BACKGROUND: Aspirin use in COPD has been associated with reduced all-cause mortality in meta-regression analysis with few equivocal studies. However, the effect of aspirin on COPD morbidity is unknown. METHODS: Self-reported daily aspirin use was obtained at baseline from SPIROMICS participants with...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Chest
Main Authors: Fawzy, Ashraf, Putcha, Nirupama, Aaron, Carrie P., Bowler, Russell P., Comellas, Alejandro P., Cooper, Christopher B., Dransfield, Mark T., Han, MeiLan K., Hoffman, Eric A., Kanner, Richard E., Krishnan, Jerry A., Labaki, Wassim W., Paine, Robert, Paulin, Laura M., Peters, Stephen P., Wise, Robert, Barr, R. Graham, Hansel, Nadia N.
Formato: Artigo
Idioma:Inglês
Publicado: American College of Chest Physicians 2019
Assuntos:
COPD
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6414789/
https://ncbi.nlm.nih.gov/pubmed/30593776
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.chest.2018.11.028
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares